Comparison 2. CVVHDF versus CVVH.
Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
---|---|---|---|---|
2.1 Circuit lifespan | 1 | 62 | Mean Difference (IV, Random, 95% CI) | 10.15 [5.15, 15.15] |
2.2 Death from any cause at 28 days | 1 | 206 | Risk Ratio (M‐H, Random, 95% CI) | 0.68 [0.52, 0.90] |
2.3 Recovery of kidney function | 1 | 96 | Risk Ratio (M‐H, Random, 95% CI) | 1.10 [0.86, 1.41] |